Data Integrity challenges in the Lab

Similar documents
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence

QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT

White paper: FDA Guidance for Industry Update Process Validation

Full Compliance Contents

Computerised Systems. Seeing the Wood from the Trees

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

FDA Guidance for Industry Update - Process Validation

Why System Suitability Tests Are Not a Substitute for Analytical Instrument Qualification

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014

Compliance Control Procedure Execution Management System Reduces Compliance Risks by 10X

Risk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems

Computerised Systems in Analytical Laboratories

Sandoz Private Limited 10/22/15

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

COTS Validation Post FDA & Other Regulations

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

Electronic Raw Data and the Use of Electronic Laboratory Notebooks

MHRA Data Integrity Guidance and Expectations Document

Validation and Calibration. Definitions and Terminology

Clinical database/ecrf validation: effective processes and procedures

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

ICH Q10 - Pharmaceutical Quality System

What is Process Validation?

Review and Approve Results in Empower Data, Meta Data and Audit Trails

Library Guide: Pharmaceutical GMPs

GxP Process Management Software. White Paper: Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

Agilent s Kalabie Electronic Lab Notebook (ELN) Product Overview ChemAxon UGM 2008 Agilent Software and Informatics Division Mike Burke

FDA Inspection Observations The FDA 483 and Beyond. Objectives

Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials

Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

This interpretation of the revised Annex

Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries

Validation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

ORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT

Harmonizing Change Control Processes Globally

Testing Automated Manufacturing Processes

How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE

Thomas Schmidt, Wolfgang Lemmerz, and Chris Stumpf Waters Corporation, Milford, MA U.S. INTRODUCTION. QC data and test result management

UNICEF s Quality Assurance System for procurement of medicines

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

Laboratory Information Management System

Siemens Industry Automation Division

World Health Organization Prequalification of Medicines

Industry Implications of Pharmaceutical Quality ICH Guidelines

B i o s o l u t i o n s

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Annex 7 Guidelines on pre-approval inspections

A Complete Drug Stability Program. Stability Lab Information Manager SL IM

Considerations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

Guideline on Process Validation

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

Lean Process Improvements for the GMP Laboratory

State of Control Over the Lifecycle and Process Validation (New and Legacy Products)

Pharmaceutical Quality Management System: Current Concept

A Pragmatic Approach to the Testing of Excel Spreadsheets

SINGLE ERP SOFTWARE VS. MULTIPLE SOFTWARE SYSTEMS. Advantages of Using One Enterprise Solution for Your Process Manufacturing Business

FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)

A Laboratory Information. Management System for the Molecular Biology Lab

Manual 074 Electronic Records and Electronic Signatures 1. Purpose

White paper: How to implement a Quality Management System

Rx-360 Supplier Assessment Questionnaire (SAQ)

MeriCal Quality Profile

Increasing Lab Efficiency by Automating Sample Test Workflows Using OpenLAB Enterprise Content Manager (ECM) and Business Process Manager (BPM)

Laboratory Data Management Systems

Implementing New USP Chapters for Analytical Method Validation

Considerations for Management of Laboratory Data

How to implement a Quality Management System

How To Control A Record System

21 CFR Part 11 White Paper

Product Lifecycle Management in the Food and Beverage Industry. An Oracle White Paper Updated February 2008

GMP Training Course Quality Control October Lesley Graham Senior Inspector (UK)

Effective Asset Management for Life Sciences

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

Process Validation: Practical Aspects of the New FDA Guidance

Guidance for Industry

Auditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories

Focused on your goals SERVICES AND SUPPORT CAPABILITIES OVERVIEW

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Workshop B Control Strategy

Software Verification and Validation

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

LabChip GX/GXII with LabChip GxP Software

Data Governance Planning PDA 12 May 2015

Compliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry.

A ChemoMetec A/S White Paper September 2013

New changes to cleanroom & clean air device classifications: ISO & 2

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

Transcription:

Data Integrity challenges in the Lab Peter Boogaard CEO Industrial Lab Automation 20 April 2016 peterboogaard@industriallabautomation.com

What makes the lab process special? Cost center perception Scientific oriented Lack of standardization Complex technologies Paper based Conservative approach

Data Integrity OPTION 1 Loss of intellectual property Potential business impact OPTION 2 Business shutdown Not in accordance with regulations

Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle

ICHQ10 Pharmaceutical Lifecycle Quality System Research Pharmaceutical Development Technology Transfer Commercial Manufacturing Discontinuation Prior Knowledge GxP Management Responsibilities Process Performance & product Quality Monitoring System Preventive Action / Corrective Action (PACA/CAPA) system Change Management System Management Review 4 PQS elements Enablers Knowledge Management Quality Risk Management

Data Integrity is cited in 50% more warning letters in 2013! Falsified batch records Testing into compliance Discarding raw data Source FDA 2013 data

US FDA Observations Summary (2013) 800 21 CFR Part 211 Observations CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS 700 600 500 400 300 200 100 0 Production & Process Controls (Subpart f) Organisational & Personal (Subpart B) Records & Reports (Subpart J) Equipment (Subpart D) Laboratory Controls (Subpart I) Inadequate investigations of Batch Failures Inadequate raw material testing Deficiencies associated with Lab controls

Laboratory data integrity observations Alteration of raw, original data and records Multiple analyses of assay with the same sample without adequate justification Manipulation of a poorly defined analytical procedure and associated data analysis in order to obtain passing results Backdating stability test results to meet the required commitments Creating acceptable test results without performing the test Using test results from previous batches to substitute testing for another batch Source: FDA

Data Integrity challenges - Devil is in the Details Laboratory processes may seem similar, but lot of details requires in-depth research to enable consistent and complete findings People Master DATA Common data dictionary Unified specification processes Reporting processes Common workflow processes United naming conventions Validation processes IT integration

Single point of truth for (meta) data Fragmented Applications Landscape Source Gartner Inc. /AMR

Single point of truth for (meta) data Data integrity Challenges Source Gartner Inc. /AMR

Scientific Data Sources

DATA INTEGRITY

Data Integrity nightmare Spreadsheet COPY/PASTE Madness Project Receive Request Lab LIMS EXCEL Receive UNILAB Lab INSTRUMENT Receive Lab FILE Cut & Paste Cut & Paste Cut & Paste Other tests Receive Lab Excel input ELN WEB Receive Lab EXPORT Other tests Excel input Receive WORDLab Cut & Paste Statistical Receive Lab Analysis Cut & Paste Top Line Receive Lab Creation Receive PDF Lab Email Receive Customer Lab

Simplify And Automate Workflows Learn from other industries Data Integrity Challenges in the Labs- PLA 2016

New Alternatives to decrease DI Courtesy of Waters Corp.

Self-documenting processes Reducing DI at the source

Adopt and use data industry standards & processes Yes, we have enough power for your equipment

GMP Regulatory Requirements for Data Integrity Instruments must be qualified and fit for purpose [ 211.160(b), 211.63] Software must be validated [ 211.63] Any calculations used must be verified [ 211.68(b)] Data generated in an analysis must be backed up [ 211.68(b)] Reagents and reference solutions are prepared correctly with appropriate records [ 211.194(c)] Methods used must be documented and approved [ 211.160(a)] Methods must be verified under actual conditions of use [ 211.194(a)(2)] Data generated and transformed must meet the criterion of scientific soundness [ 211.160(a)] Test data must be accurate and complete and follow procedures [ 211.194(a)] Data and the reportable value must be checked by a second individual to ensure accuracy, completeness and conformance with procedures [ 211.194(a)(8)] Derived from the laboratory data integrity definition and the applicable 21 CFR 211 GMP regulations FDA s Focus on lab Data integrity Bob McDowall Part 1

Methods to increase integrity in the laboratory Conclusion Implement Risk based processes Define a single point of truth for (meta) data Reduce, automate & simplify workflow complexities Stop spreadsheet madness Implement self-documenting processes at the source Utilize best practice analysis protocols Adopt and use data industry standards & processes Avoid custom software extensions

Data Integrity Challenges in the Labs- PLA 2016

Data Integrity challenges in the Lab Peter Boogaard CEO Industrial Lab Automation 20 April 2016 peterboogaard@industriallabautomation.com www.industriallabautomation.com

Laboratory Life Cycle model Meta data capture Analytical data Process data Predicted information Statistical data Laboratory knowledge Regulatory External data consumers